David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 31,361 shares at $1.66 ($53K) on 2018-11-14, disclosed to the SEC on 2018-11-15.
Scheduled sale ($53k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.70 | 536 | $911 | 1.7% |
| 2 | $1.70 | 1,161 | $2K | 3.7% |
| 3 | $1.70 | 16,164 | $27K | 52.1% |
| 4 | $1.66 | 405 | $672 | 1.3% |
| 5 | $1.66 | 877 | $1K | 2.8% |
| 6 | $1.66 | 12,218 |
| $20K |
| 38.4% |
| Total | $1.68 avg | 31,361 | $53K | 100% |
| Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |
| GEN | SELL | 2018-11-07 | $18K | — | Filing → |